Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase vs alteplase for ultra-early ischemic stroke (≤4.5h onset)
CTR20201936Phase 2Completed
- Sponsor
- World Trade Tianjie Pharmaceuticals
- Start
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tenecteplase in ischemic stroke, sponsored by World Trade Tianjie Pharmaceuticals. Started Sep 2020; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20201936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201936.